Ketamine lifts depression via a byproduct of its metabolism, says NIH Study

By |2016-05-07T11:15:00-07:00May 7th, 2016|We Know Psychiatry|

Is Special K the Anti-Depressant We’ve Waited For? A groundbreaking study on the popular club drug shows its massive potential in treating depression, with a ketamine spray coming to market as soon as 2019. According to The Daily Beast, infamous pharma bro Martin Shkreli’s company Turing Pharmaceuticals recently inked a $95 [...]